These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6222712)

  • 21. Cerebral blood flow and metabolism during cardiopulmonary bypass with special reference to effects of hypotension induced by prostacyclin.
    Feddersen K; Arén C; Nilsson NJ; Rådegran K
    Ann Thorac Surg; 1986 Apr; 41(4):395-400. PubMed ID: 3083793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
    Coppe D; Sobel M; Seamans L; Levine F; Salzman E
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiopulmonary bypass induces release of soluble CD40 ligand.
    Nannizzi-Alaimo L; Rubenstein MH; Alves VL; Leong GY; Phillips DR; Gold HK
    Circulation; 2002 Jun; 105(24):2849-54. PubMed ID: 12070112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with prostacyclin in cardiopulmonary bypass in dog and man.
    Longmore DB
    Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):399-412. PubMed ID: 6117901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass.
    Teoh KH; Christakis GT; Weisel RD; Wong PY; Mee AV; Ivanov J; Madonik MM; Levitt DS; Reilly PA; Rosenfeld JM
    J Thorac Cardiovasc Surg; 1988 Aug; 96(2):332-41. PubMed ID: 3398555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cardiopulmonary bypass and prostacyclin on plasma catecholamines, angiotensin II and arginine-vasopressin.
    Feddersen K; Aurell M; Delin K; Häggendal J; Arén C; Rådegran K
    Acta Anaesthesiol Scand; 1985 Feb; 29(2):224-30. PubMed ID: 3883684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss.
    Wagner WR; Johnson PC; Thompson KA; Marrone GC
    Ann Thorac Surg; 1994 Sep; 58(3):734-40; discussion 741. PubMed ID: 7944696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nafamostat mesilate reduces blood loss during open heart surgery.
    Murase M; Usui A; Tomita Y; Maeda M; Koyama T; Abe T
    Circulation; 1993 Nov; 88(5 Pt 2):II432-6. PubMed ID: 8222190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of aprotinin on prostaglandin metabolism and platelet function in open heart surgery.
    Nagaoka H; Innami R; Murayama F; Funakoshi N; Hirooka K; Watanabe M; Satoh M
    J Cardiovasc Surg (Torino); 1991; 32(1):31-7. PubMed ID: 1707053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass.
    Dietrich W; Spannagl M; Schramm W; Vogt W; Barankay A; Richter JA
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):505-14. PubMed ID: 1833592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of acquired transient defect in platelet plug formation by infused prostacyclin.
    Malpass TW; Hanson SR; Savage B; Hessel EA; Harker LA
    Blood; 1981 Apr; 57(4):736-40. PubMed ID: 7008866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent.
    Zusman RM; Rubin RH; Cato AE; Cocchetto DM; Crow JW; Tolkoff-Rubin N
    N Engl J Med; 1981 Apr; 304(16):934-9. PubMed ID: 7010166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostacyclin in cardiopulmonary bypass operations.
    Faichney A; Davidson KG; Wheatley DJ; Davidson JF; Walker ID
    J Thorac Cardiovasc Surg; 1982 Oct; 84(4):601-8. PubMed ID: 6750247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatosensory evoked potentials and cerebral metabolism during cardiopulmonary bypass with special reference to hypotension induced by prostacyclin infusion.
    Arén C; Badr G; Feddersen K; Rådegran K
    J Thorac Cardiovasc Surg; 1985 Jul; 90(1):73-9. PubMed ID: 3925243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
    Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
    Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
    Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative management of patients with heparin-induced thrombocytopenia.
    Kappa JR; Fisher CA; Todd B; Stenach N; Bell P; Campbell F; Ellison N; Addonizio VP
    Ann Thorac Surg; 1990 May; 49(5):714-22; discussion 723. PubMed ID: 1692679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of ulinastatin on coagulation and platelet function in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass].
    Ji HW; Chen L
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(3):175-8. PubMed ID: 19537033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
    Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH
    Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.